Bioavailability, Cosmetics and Manufacturing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioavailability

Cosmetics

Manufacturing

Nanoparticles: Emerging Stars for Pharmaceutical Industry

Roots Analysis

FEBRUARY 20, 2022

In fact, it has been observed that around 40% of the pharmaceutical products approved by regulatory organizations exhibit poor bioavailability / solubility. Further, every year, poor bioavailability is one of the prime reasons that leads to failure in obtaining approval authorization.

Contract Manufacturing

Contract Manufacturing Bioavailability Manufacturing Drug Delivery Systems

What does the FDA animal testing legislation mean for drug discovery?

Drug Discovery World

FEBRUARY 2, 2023

As simplified in a press release by the National Association for Biomedical Research (NABR), the act amends the Federal Food, Drug, and Cosmetic Act (21 U.S.C. As reported by DDW , the system will initially be investigated for improving the preclinical estimation of human drug bioavailability compared to standard animal models.

Drugs

Drugs Clinical Trials Clinical Trials Cosmetics

Clinical Research Informer

Nanoparticles: Emerging Stars for Pharmaceutical Industry

What does the FDA animal testing legislation mean for drug discovery?

Stay Connected